Researcher
Jan Vermorken
- Research Expertise:- cell culture - pharmacological analyses
- Keywords:CANCER, ONCOLOGY, CELLULAR TECHNIQUES, Medicine
- Disciplines:Morphological sciences, Oncology, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
- Research techniques:-cell culture -HPLC
- Users of research expertise:university researchers
Affiliations
- Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO) (Research group)
Member
From1 Oct 2009 → 31 Dec 2018 - Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO) (Research group)
Member
From1 Oct 2003 → 30 Sep 2009
Projects
1 - 1 of 1
- Colorectal cancer: biological factors as molecular markers for a more targeted therapy.From1 Oct 2009 → 30 Sep 2011Funding: Nonprofit institution or equivalents
Publications
41 - 50 of 275
- Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status(2020)
Authors: Hasan Baysal, Ines De Pauw, Hannah Zaryouh, Jorrit De Waele, Marc Peeters, Patrick Pauwels, Jan Vermorken, Evelien Smits, Filip Lardon, Julie Jacobs, et al.
Pages: 1 - 10 - Follow-up of head and neck cancer survivors(2020)
Authors: Petr Szturz, Carl Van Laer, Christian Simon, Dirk Van Gestel, Jean Bourhis, Jan Vermorken
Pages: 1 - 9 - Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic(2020)
Authors: Aline Lauda Freitas Chaves, Ana Ferreira Castro, Gustavo Nader Marta, Gilberto Castro Junior, Robert L. Ferris, Raul Eduardo Giglio, Wojciech Golusinski, Philippe Gorphe, Sefik Hosal, C. Rene Leemans, et al.
Pages: 1 - 4 - Current management of stage IV nasopharyngeal carcinoma without distant metastasis(2020)
Authors: Wai Tong Ng, June Corry, Johannes A. Langendijk, Anne W. M. Lee, Antti Makitie, William M. Mendenhall, Alessandra Rinaldo, Juan P. Rodrigo, Nabil F. Saba, Robert Smee, et al.
Pages: 1 - 10 - SARS-CoV-2 and cancer(2020)
Authors: Peter Van Dam, Manon Huizing, Gino Mestach, Stazie Dierckxsens, Wiebren Tjalma, Xuan Bich Trinh, Kostantinos Papadimitriou, Sevilay Altintas, Jan Vermorken, Christof Vulsteke, et al.
- Low-dose vs. high-dose cisplatin(2019)
Authors: Petr Szturz, Naomi Kiyota, Makoto Tahara, Kumar Prabhash, Vanita Noronha, David Adelstein, Dirk Van Gestel, Jan Vermorken
- Cisplatin eligibility issues and alternative regimens in locoregionally advanced head and neck cancer(2019)
Authors: Petr Szturz, Valerie Cristina, Ruth Gabriela Herrera Gomez, Jean Bourhis, Christian Simon, Jan Vermorken
- Prognostic and predictive factors in recurrent and/or metastatic head and neck squamous cell carcinoma: A review of the literature(2019)
Authors: Paolo Bossi, Salvatore Alfieri, Primoz Strojan, Robert P. Takes, Fernando Lopez, Antti Makitie, Nabil F. Saba, Juan Pablo Rodrigo, Carol Bradford, Carlos Suarez, et al.
Pages: 84 - 91 - Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck(2019)
Authors: Robert Haddad, Joel Guigay, Ulrich Keilholz, Paul M. Clement, Jerome Fayette, Luciano Souza de Viana, Frederic Rolland, Didier Cupissol, Lionnel Geoffrois, Gabriela Kornek, et al.
Pages: 82 - 91 - Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma(2019)
Authors: Y. -P. Chen, Y. -Q. Wang, J. -W. Lv, Y. -Q. Li, M. L. K. Chua, Q. -T. Le, N. Lee, A. Dimitrios Colevas, T. Seiwert, D. N. Hayes, et al.
Pages: 68 - 75